Apogee Therapeutics, Inc. (APGE) earnings
APGE earnings moved a median of +0.23% by the close. Quarterly and annual APGE reports and results, each read against the price at its own news timestamp. Back to the APGE overview →
20 measured APGE earnings events.
Where these APGE earnings landedvs 18 measured APGE earnings reactions
| Middle 50% of APGE earnings reactions | -2.38% to +1.01% |
|---|---|
| Median reaction (to close) | +0.23% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 APGE earnings events with a measured close landed between -2.38% and +1.01%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates | Press release | +0.01% | — | |
| Form 10-Q Apogee Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.01% | — | |
| Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results | Press release | +0.01% | +0.73% | |
| Form 10-Q Apogee Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.01% | +0.73% | |
| Form 10-K Apogee Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.57% | +4.44% | |
| Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results | Press release | +0.98% | +1.01% | |
| Form 10-Q Apogee Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.98% | +1.01% | |
| Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results | Press release | -0.69% | -2.09% | |
| Form 10-Q Apogee Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.69% | -2.09% | |
| Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results | Press release | -1.49% | +0.23% | |
| Form 10-Q Apogee Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.49% | +0.23% | |
| Form 10-K Apogee Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +6.06% | -3.89% | |
| Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results | Press release | -0.61% | -4.80% | |
| Form 10-Q Apogee Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.61% | -4.80% | |
| Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results | Press release | +1.80% | +11.21% | |
| Form 10-Q Apogee Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.80% | +11.21% | |
| Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results | Press release | -0.18% | -2.48% | |
| Form 10-Q Apogee Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.18% | -2.48% | |
| Form 10-K Apogee Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +4.26% | -1.17% | |
| Apogee Highlights Corporate Progress and Reports Third Quarter 2023 Financial Results | Press release | +0.67% | +9.19% |
Keep exploring
More APGE: analyst actions → · SEC filings → · APGE overview →